Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/4338Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Marina Kordze | - |
| dc.date.accessioned | 2026-05-16T12:10:15Z | - |
| dc.date.available | 2026-05-16T12:10:15Z | - |
| dc.date.issued | 2026-05-16 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/4338 | - |
| dc.description | Vol. 56, No. 2, p93 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Breast adenocarcinoma | en_US |
| dc.subject | Cancer | en_US |
| dc.subject | Estradiol | en_US |
| dc.subject | Fibroadenoma | en_US |
| dc.subject | Prolactin | en_US |
| dc.subject | Thyroid-stimulating hurmone | en_US |
| dc.subject | TSH | en_US |
| dc.subject | Thyroxin (fT4) | en_US |
| dc.title | Hormonal status and distribution of ABO system phenotypic groups in menopausal and postmenopausal women with breast tumors | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol 56, No. 2, 2018 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.